查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1293911

血管栓塞市场：按栓塞技术（捲绕装置、非捲绕装置）、按应用（神经学、肿瘤学、周围血管疾病）、最终用户 - 俄罗斯-乌克兰衝突和高通胀 - 2023-2030 年全球预测

Vascular Embolization Market by Embolization Technique (Coiling Devices, Non-Coiling Devices), Application (Neurology, Oncology, Peripheral Vascular Disease), End-User - Russia Ukraine Conflict and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2023 年，全球血管栓塞市场将达到 20.9671 亿美元，复合年增长率为 11.31%，预计到 2030 年将出现惊人增长，达到 44.5897 亿美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球血管栓塞市场至关重要。 通过检查业务战略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的具体需求做出明智的决策。 这种高级分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市场份额分析

市场份额分析可以深入了解供应商在特定市场区域的当前状态。 比较供应商对整体收入、客户群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。 该分析还揭示了特定行业的竞争程度、积累和分散的优势以及研究基准年的併购特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要公司所服务的市场的全面信息。

2. 市场开发：提供有关利润丰厚的新兴市场的详细信息，并分析其在成熟市场领域的渗透率。

3. 市场多元化：提供有关新产品发布、未开发地区、最新开发和投资的详细信息。

4. 市场趋势：全面了解 COVID-19、俄罗斯-乌克兰衝突和高通胀的累积影响。

5.竞争评估与信息：对各大公司的市场份额、战略、产品、认证、监管状况、专利状况、製造能力进行综合评估。

6. 产品开发和创新：提供对未来技术、研发活动和突破性产品开发的见解。

此报告回答了以下问题：

1.全球血管栓塞市场规模及预测是多少？

2. 在预测期内，COVID-19 对全球血管栓塞市场的抑制因素和影响有哪些？

3.在预测期内，全球血管栓塞市场需要投资哪些产品/细分市场/应用/领域？

4.你们在全球血管栓塞市场的竞争策略是什么？

5.全球血管栓塞市场的技术趋势和监管框架是什么？

6.全球血管栓塞市场主要厂商的市场份额是多少？

7.什么形式和战略举措被认为适合进入全球血管栓塞市场？

目录

第1章前言

第2章研究方法

第 3 章执行摘要

第4章市场概述

第 5 章市场洞察

  • 市场动态
    • 促进因素
      • 血管疾病患病率不断上升
      • 对微创手术的偏好日益增加
      • 栓塞产品和技术的开发
    • 抑制因素
      • 与栓塞相关的高成本
    • 机会
      • 血管栓塞生物材料和技术的进展
    • 作业
      • 与栓塞相关的并发症
  • 市场趋势
  • 新冠肺炎 (COVID-19) 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通胀的累积影响
  • 波特五力分析
  • 价值炼和关键路径分析
  • 监管框架
  • 客户定制

第6章按栓塞技术划分的血管栓塞市场

  • 捲取装置
  • 非捲取装置

第7章血管栓塞市场：按应用

  • 神经病学
  • 肿瘤学
  • 周围血管疾病
  • 泌尿科

第 8 章血管栓塞市场：按最终用户划分

  • 门诊手术中心
  • 诊断中心
  • 医院
  • 专科诊所

第9章北美和南美血管栓塞市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太地区血管栓塞市场

  • 澳大利亚
  • 中国
  • 印度
  • 印度尼西亚
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第11章欧洲、中东和非洲血管栓塞市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 意大利
  • 荷兰
  • 尼日利亚
  • 挪威
  • 波兰
  • 卡塔尔
  • 俄罗斯
  • 沙特阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯联合酋长国
  • 英国

第12章竞争态势

  • FPNV定位矩阵
  • 市场份额分析：按主要公司划分
  • 竞争情景分析：主要公司

第13章上市公司名单

第14章附录

  • 讨论指南
  • 关于许可证和价格
Product Code: MRR-742BD5184D6E

The Global Vascular Embolization Market is forecasted to grow significantly, with a projected USD 2,096.71 million in 2023 at a CAGR of 11.31% and expected to reach a staggering USD 4,458.97 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Vascular Embolization Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Vascular Embolization Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Embolization Technique, market is studied across Coiling Devices and Non-Coiling Devices. The Non-Coiling Devices is projected to witness significant market share during forecast period.

Based on Application, market is studied across Neurology, Oncology, Peripheral Vascular Disease, and Urology. The Neurology is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Ambulatory Surgical Centers, Diagnostics Centers, Hospitals, and Specialty Clinics. The Ambulatory Surgical Centers is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Vascular Embolization Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Vascular Embolization Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Vascular Embolization Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Vascular Embolization Market?

4. What is the competitive strategic window for opportunities in the Global Vascular Embolization Market?

5. What are the technology trends and regulatory frameworks in the Global Vascular Embolization Market?

6. What is the market share of the leading vendors in the Global Vascular Embolization Market?

7. What modes and strategic moves are considered suitable for entering the Global Vascular Embolization Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Vascular Embolization Market, by Embolization Technique, 2022 vs 2030
  • 4.3. Vascular Embolization Market, by Application, 2022 vs 2030
  • 4.4. Vascular Embolization Market, by End-User, 2022 vs 2030
  • 4.5. Vascular Embolization Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of vascular diseases
      • 5.1.1.2. Increasing preference for minimally invasive procedures
      • 5.1.1.3. Development in embolization products and procedures
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with embolization procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Advances in biomaterials and technologies for vascular embolization
    • 5.1.4. Challenges
      • 5.1.4.1. Complications associated with embolization procedures
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Vascular Embolization Market, by Embolization Technique

  • 6.1. Introduction
  • 6.2. Coiling Devices
  • 6.3. Non-Coiling Devices

7. Vascular Embolization Market, by Application

  • 7.1. Introduction
  • 7.2. Neurology
  • 7.3. Oncology
  • 7.4. Peripheral Vascular Disease
  • 7.5. Urology

8. Vascular Embolization Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Diagnostics Centers
  • 8.4. Hospitals
  • 8.5. Specialty Clinics

9. Americas Vascular Embolization Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Vascular Embolization Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Vascular Embolization Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

1. Abbott Laboratories

2. B. Braun Melsungen AG

3. Becton, Dickinson and Company

4. Boston Scientific Corporation

5. Cook Medical Inc.

6. Kaneka Corporation

7. Lepu Medical Technology Co.,Ltd.

8. Medtronic PLC

9. Merit Medical Systems Inc.

10. Penumbra Inc

11. Shape Memory Medical Inc.

12. Stryker Corporation

13. Terumo Corporation

14. W. L. Gore & Associates Inc.

15. WEGO Healthcare Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. VASCULAR EMBOLIZATION MARKET RESEARCH PROCESS
  • FIGURE 2. VASCULAR EMBOLIZATION MARKET SIZE, 2022 VS 2030
  • FIGURE 3. VASCULAR EMBOLIZATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2022 VS 2030 (%)
  • FIGURE 5. VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 6. VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 7. VASCULAR EMBOLIZATION MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. VASCULAR EMBOLIZATION MARKET DYNAMICS
  • FIGURE 9. VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. VASCULAR EMBOLIZATION MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. VASCULAR EMBOLIZATION MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. VASCULAR EMBOLIZATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. VASCULAR EMBOLIZATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 5. VASCULAR EMBOLIZATION MARKET SIZE, BY COILING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. VASCULAR EMBOLIZATION MARKET SIZE, BY NON-COILING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 8. VASCULAR EMBOLIZATION MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. VASCULAR EMBOLIZATION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. VASCULAR EMBOLIZATION MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. VASCULAR EMBOLIZATION MARKET SIZE, BY UROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 13. VASCULAR EMBOLIZATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. VASCULAR EMBOLIZATION MARKET SIZE, BY DIAGNOSTICS CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. VASCULAR EMBOLIZATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. VASCULAR EMBOLIZATION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. VASCULAR EMBOLIZATION MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 145. VASCULAR EMBOLIZATION MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 146. VASCULAR EMBOLIZATION MARKET LICENSE & PRICING